Tandem Diabetes Care INC Form 4 insider transactions

Director Dick Allen reported a gift of Tandem Diabetes Care shares and holdings in family trusts.

EVP & Chief Operating Officer of Tandem Diabetes Care, Jean-Claude Kyrillos, reports the acquisition of 43,634 restricted stock units.

Rick Carpenter, Chief Technology Officer of Tandem Diabetes Care, reports the vesting of restricted stock units and subsequent tax withholding.

Myoungil Cha, a director at Tandem Diabetes Care, exercised stock options and now directly owns 7,563 shares of common stock.

Director Joao Paulo Falcao Malagueira exercised stock options in Tandem Diabetes Care, acquiring 1,749 shares of common stock.

Director Dick Allen transfers shares of Tandem Diabetes Care stock to a family trust and discloses indirect ownership through another trust.

Elizabeth Anne Gasser, EVP and Chief Strategy Officer of Tandem Diabetes Care, transferred shares to The Gasser Family Trust.

Director Dick Allen reports a gift of Tandem Diabetes Care shares to The Gammon Family Trust and details beneficial ownership through family trusts.

Director Dick Allen sold 5,000 shares of Tandem Diabetes Care Inc. on May 30, 2024, at an average price of $51.68 per share.

EVP and CFO of Tandem Diabetes Care, Leigh Vosseller, reports acquisition and disposal of company stock and derivative securities.

James Leal, Chief Manufacturing Officer of Tandem Diabetes Care, reports the acquisition and disposal of company stock and restricted stock units.

John F. Sheridan, CEO of Tandem Diabetes Care, reports acquisition and disposal of company stock and derivative securities.

Mark David Novara, EVP & Chief Commercial Officer of Tandem Diabetes Care, received restricted and performance stock units on May 23, 2024, under the company's 2023 Long-Term Incentive Plan.

Elizabeth Gasser, EVP and Chief Strategy Officer at Tandem Diabetes Care, reports acquisition and disposal of common stock and derivative securities, including restricted stock units and performance stock units.

EVP & Chief Admin. Officer Susan Morrison reports acquisition and disposal of Tandem Diabetes Care stock and derivative securities.

Rick Carpenter, Chief Technology Officer of Tandem Diabetes Care, reports the acquisition of restricted stock units and performance stock units.

Shannon Marie Hansen, Chief Legal Officer of Tandem Diabetes Care, reports the acquisition of restricted stock units and performance stock units.

Director Myoungil Cha reports acquisition and disposal of Tandem Diabetes Care stock and restricted stock units.

Director Peyton R. Howell reports acquisition and disposal of Tandem Diabetes Care stock and restricted stock units.

Director Christopher Twomey reports acquisition and disposal of Tandem Diabetes Care stock and restricted stock units.

Director Kathleen McGroddy-Goetz reports acquisition and disposal of Tandem Diabetes Care stock and restricted stock units.

Director Joao Paulo Falcao Malagueira reports acquisition and disposal of Tandem Diabetes Care stock and restricted stock units.

Director Rajwant Sodhi reports acquisition and disposal of Tandem Diabetes Care stock and restricted stock units.

Director Rebecca Robertson reports acquisition and disposal of Tandem Diabetes Care stock and restricted stock units.

Director Dick Allen reports acquisition and disposal of Tandem Diabetes Care stock and restricted stock units.

Director Kim Blickenstaff reports acquisition and disposal of Tandem Diabetes Care stock and restricted stock units.

EVP and Chief Strategy Officer of Tandem Diabetes Care, Elizabeth Gasser, reports acquisition and disposal of company stock and restricted stock units.

EVP & Chief Admin. Officer of Tandem Diabetes Care, Susan Morrison, reports acquisition and disposal of company stock and restricted stock units.

Rick Carpenter, Chief Technology Officer of Tandem Diabetes Care, reports acquisition and disposal of company stock and restricted stock units.

Leigh Vosseller, EVP & CFO of Tandem Diabetes Care, reports acquisition and disposal of company stock and restricted stock units (RSUs) on May 15, 2024.